This role involves spearheading the advancement of innovative IHC methodologies specifically for non-clinical radioconjugate discovery projects in oncology within AstraZeneca.
Base: $131,201.60 to $172,202.10; Bonus/Equity: Annual Variable Pay Bonus and equity-based long-term incentive program eligibility; Benefits: Competitive Flex Benefits, Retirement Savings Program, 4 weeks vacation, annual Personal Days
Must-have
Nice-to-have
Not specified